Literature DB >> 16048434

The granule pathway of programmed cell death.

Philip G Ashton-Rickardt1.   

Abstract

The exocytosis of death-inducing granzymes stored in the granules of cytotoxic lymphocytes allows the immune system to rapidly eliminate intracellular pathogens and transformed cells. The membrane-disrupting protein perforin allows the entry of granzymes into a cell, where they induce apoptosis by cleaving target substrates in the cytoplasm and nucleus. Granzymes kill cells in a variety of ways. Recent work has demonstrated that granzymes induce mitochondrial dysfunction through caspase and caspase-independent pathways and destroy DNA and the integrity of the nucleus. Cytotoxic lymphocytes are susceptible to self-inflicted damage. Mice and humans defective in perforin and granzymes point to a role for self-inflicted damage in downregulating lymphocyte responses. Given the propensity for the granule pathway to inflict cellular damage, cytotoxic lymphocytes have developed a variety of mechanisms to protect themselves. In this regard, endogenous serine protease inhibitors have been suggested to protect cytotoxic lymphocytes from granzyme B. It would appear that certain viruses and possibly even tumor cells also use the same mechanism to escape destruction from the exocytosis pathway of programmed cell death.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16048434     DOI: 10.1615/critrevimmunol.v25.i3.10

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  17 in total

1.  Absence of perforin expression confers axonal protection despite demyelination.

Authors:  Charles L Howe; Jaimie D Adelson; Moses Rodriguez
Journal:  Neurobiol Dis       Date:  2006-11-16       Impact factor: 5.996

2.  IFN-gamma-producing dendritic cells are important for priming of gut intraepithelial lymphocyte response against intracellular parasitic infection.

Authors:  Magali M Moretto; Louis M Weiss; Crescent L Combe; Imtiaz A Khan
Journal:  J Immunol       Date:  2007-08-15       Impact factor: 5.422

3.  Immune-mediated changes in actinic keratosis following topical treatment with imiquimod 5% cream.

Authors:  Abel Torres; Leslie Storey; Makala Anders; Richard L Miller; Barbara J Bulbulian; Jizhong Jin; Shalini Raghavan; James Lee; Herbert B Slade; Woubalem Birmachu
Journal:  J Transl Med       Date:  2007-01-26       Impact factor: 5.531

4.  Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell properties.

Authors:  Rachel L Rutishauser; Gislâine A Martins; Sergey Kalachikov; Anmol Chandele; Ian A Parish; Eric Meffre; Joshy Jacob; Kathryn Calame; Susan M Kaech
Journal:  Immunity       Date:  2009-08-06       Impact factor: 31.745

5.  Detection of Cancer Cell Death Mediated by a Synthetic Granzyme B-like Peptide Fluorescent Conjugate and the same Peptide Binding in Bacteria.

Authors:  Wai Chun Jennifer Lo; Donald Gene Luther
Journal:  J Fluoresc       Date:  2013-10-24       Impact factor: 2.217

6.  Immunity and immune suppression in human ovarian cancer.

Authors:  Claudia C Preston; Ellen L Goode; Lynn C Hartmann; Kimberly R Kalli; Keith L Knutson
Journal:  Immunotherapy       Date:  2011-04       Impact factor: 4.196

7.  Perforin gene mutations in patients with acquired aplastic anemia.

Authors:  Elena E Solomou; Federica Gibellini; Brian Stewart; Daniela Malide; Maria Berg; Valeria Visconte; Spencer Green; Richard Childs; Stephen J Chanock; Neal S Young
Journal:  Blood       Date:  2007-02-20       Impact factor: 22.113

8.  Distinct profiles of cytotoxic granules in memory CD8 T cells correlate with function, differentiation stage, and antigen exposure.

Authors:  Alexandre Harari; Felicitas Bellutti Enders; Cristina Cellerai; Pierre-Alexandre Bart; Giuseppe Pantaleo
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

Review 9.  The immune system in the pathogenesis of ovarian cancer.

Authors:  Bridget Charbonneau; Ellen L Goode; Kimberly R Kalli; Keith L Knutson; Melissa S Derycke
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

10.  Caspase-dependent inhibition of mousepox replication by gzmB.

Authors:  Julián Pardo; Eva María Gálvez; Aulikki Koskinen; Markus M Simon; Mario Lobigs; Matthias Regner; Arno Müllbacher
Journal:  PLoS One       Date:  2009-10-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.